Tech Company Financing Transactions
Metactive Medical Funding Round
On 3/9/2018, Metactive Medical announced $1.2 million in Series A funding from Mid-America Angels and Serra Ventures.
Transaction Overview
Company Name
Announced On
3/9/2018
Transaction Type
Venture Equity
Amount
$1,200,000
Round
Series A
Investors
Mid-America Angels (Laura Classen)
Proceeds Purpose
This new investment capital and grant funding will be used to continue the development of our novel platform of embolic products, which we believe will provide physicians with devices that are exceptionally deliverable, can be placed with a high level of precision, are resistant to migration, and provide immediate, complete, and lasting occlusion, stated F. Nicholas Franano, MD, President and CEO of Metactive.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
10900 S. Clay Blair Blvd.
Olathe, KS 66061
USA
Olathe, KS 66061
USA
Phone
Undisclosed
Website
Email Address
Overview
Metactive is developing novel, endovascular medical devices for the treatment of peripheral and neurovascular diseases. Metactive's first products enable precise and immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nicholas Franano
Browse more venture capital transactions:
Prev: 3/9/2018: Poka venture capital transaction
Next: 3/9/2018: PolicyPal venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs